501 related articles for article (PubMed ID: 33766485)
1. Insulin resistance, cardiovascular stiffening and cardiovascular disease.
Hill MA; Yang Y; Zhang L; Sun Z; Jia G; Parrish AR; Sowers JR
Metabolism; 2021 Jun; 119():154766. PubMed ID: 33766485
[TBL] [Abstract][Full Text] [Related]
2. Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness.
Hill MA; Jaisser F; Sowers JR
Cardiovasc Res; 2022 Jan; 118(1):130-140. PubMed ID: 33188592
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
Whaley-Connell A; Johnson MS; Sowers JR
Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
[TBL] [Abstract][Full Text] [Related]
4. Epithelial sodium channels in endothelial cells mediate diet-induced endothelium stiffness and impaired vascular relaxation in obese female mice.
Sowers JR; Habibi J; Aroor AR; Yang Y; Lastra G; Hill MA; Whaley-Connell A; Jaisser F; Jia G
Metabolism; 2019 Oct; 99():57-66. PubMed ID: 31302199
[TBL] [Abstract][Full Text] [Related]
5. Sexual Dimorphism in Obesity-Associated Endothelial ENaC Activity and Stiffening in Mice.
Padilla J; Woodford ML; Lastra-Gonzalez G; Martinez-Diaz V; Fujie S; Yang Y; Lising AMC; Ramirez-Perez FI; Aroor AR; Morales-Quinones M; Ghiarone T; Whaley-Connell A; Martinez-Lemus LA; Hill MA; Manrique-Acevedo C
Endocrinology; 2019 Dec; 160(12):2918-2928. PubMed ID: 31617909
[TBL] [Abstract][Full Text] [Related]
6. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
Sowers JR; Whaley-Connell A; Epstein M
Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular actions of insulin.
Muniyappa R; Montagnani M; Koh KK; Quon MJ
Endocr Rev; 2007 Aug; 28(5):463-91. PubMed ID: 17525361
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles in Metabolic and Vascular Insulin Resistance.
Malin SK; Erdbrügger U
J Vasc Res; 2024; 61(3):129-141. PubMed ID: 38615667
[TBL] [Abstract][Full Text] [Related]
9. Western diet induces renal artery endothelial stiffening that is dependent on the epithelial Na
Xiong Y; Aroor AR; Ramirez-Perez FI; Jia G; Habibi J; Manrique-Acevedo C; Lastra G; Chen D; DeMarco VG; Martinez-Lemus LA; Hill MA; Jaisser F; Sowers JR; Whaley-Connell A
Am J Physiol Renal Physiol; 2020 May; 318(5):F1220-F1228. PubMed ID: 32281419
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell serum and glucocorticoid regulated kinase 1 (SGK1) mediates vascular stiffening.
Zhang L; Sun Z; Yang Y; Mack A; Rodgers M; Aroor A; Jia G; Sowers JR; Hill MA
Metabolism; 2024 May; 154():155831. PubMed ID: 38431129
[TBL] [Abstract][Full Text] [Related]
11. Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act.
Muniyappa R; Yavuz S
Mol Cell Endocrinol; 2013 Sep; 378(1-2):59-69. PubMed ID: 22684034
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.
Henry RM; Ferreira I; Dekker JM; Nijpels G; Scheffer PG; Stehouwer CD
J Hum Hypertens; 2009 Nov; 23(11):718-27. PubMed ID: 19279658
[TBL] [Abstract][Full Text] [Related]
13. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
Zhou MS; Schulman IH; Zeng Q
Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
[TBL] [Abstract][Full Text] [Related]
14. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.
Vincent MA; Montagnani M; Quon MJ
Curr Diab Rep; 2003 Aug; 3(4):279-88. PubMed ID: 12866989
[TBL] [Abstract][Full Text] [Related]
15. Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction.
Jia G; Habibi J; Aroor AR; Hill MA; Yang Y; Whaley-Connell A; Jaisser F; Sowers JR
Hypertension; 2018 Sep; 72(3):731-738. PubMed ID: 29987101
[TBL] [Abstract][Full Text] [Related]
16. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.
Cleland SJ; Petrie JR; Ueda S; Elliott HL; Connell JM
Clin Exp Pharmacol Physiol; 1998; 25(3-4):175-84. PubMed ID: 9590566
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
Bender SB; McGraw AP; Jaffe IZ; Sowers JR
Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms underlying obesity-induced arterial stiffness.
Aroor AR; Jia G; Sowers JR
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R387-R398. PubMed ID: 29167167
[TBL] [Abstract][Full Text] [Related]
19. Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors.
Brillante DG; O'Sullivan AJ; Howes LG
Vasc Health Risk Manag; 2009; 5(1):73-8. PubMed ID: 19436651
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
